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Objective: To evaluate the safety dose range of ethanolic extract from the leaves of
Pericampylus glaucus (Lam.) Merr. by acute and sub-acute oral toxicity study on animal
model.
Methods: The acute and sub-acute toxicity study was carried out as per Organization for
Economic Co-operation and Development guidelines 423 and 407. In acute toxicity
study, the oral dose (300, 2000 and 4000 mg/kg) of tested plant extract was administered
to three groups in single dose and general behavior, adverse effects and mortality were
determined up to 72 h and compared to normal group. In sub-acute study, the tested crude
plant extract was administered orally at doses of 600 and 1000 mg/kg for 28 days to the
two animals groups and their body weight, hematological, serum hepatic biochemical
parameters were evaluated and compared to normal group by sacriﬁcing all group
animals.
Results: In acute toxicity, all treated groups’ revealed neither mortality nor any signif-
icant alteration in behavior only drowsiness, sedation and lethargy were observed in two
group, i.e. 2000 and 4000 mg/kg of the tested plant extract. In sub-acute toxicity study no
change in hematological, biochemical parameter and organ body weight were observed
during study compared to the normal group. The kidney function parameters [serum
glutamic-oxaloacetic transaminase (aspartate transaminase), serum glutamic pyruvic
transaminase (alanine transaminase)] were signiﬁcantly increased following administra-
tion of tested crude plant extract (600, 1000 mg/kg).
Conclusions: The result indicates that the oral administration of Pericampylus glaucus
(Lam.) Merr. extract did not produce any signiﬁcant toxic effect in BALB/c mice.
Hence, the extract can be utilized safely for therapeutic use in pharmaceutical
formulations.1. Introduction
The use of traditional medicine is an important part in
Malaysian culture and was practiced by ancients long before
the introduction of modern medicine. A complete report on the
Malay traditional medicinal plants were compiled in a book
entitled “A Dictionary of the Economic Products of the Malay
Peninsula”. This book had become the starting point for the
phytochemists and ethno-botanist to do some studies andresearch relating to the medicinal plants. All of these works add
a comprehensive knowledge to the account of Malaysian me-
dicinal plants[1,2]. In Malaysia, the plants of the
Menispermaceae family are known to be rich source of
bioactive compounds that have signiﬁcant role in curing of
various diseases. The genus Pericampylus glaucus (Lam.)
Merr. (P. glaucus) belongs to the family of Menispermaceae
and is commonly found in ground and forest area of the
whole Malaysia. It also occurs in Thailand, India, China,
Indonesia, Myanmar, Taiwan, Philippine, and Vietnam[3]. In
Malaysia the traditional name of the plant is commonly
known as “akar chuping”[4]. The plant is climber shrubs and
the young stems are often long slender and yellowish inreserved.
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spiral, simple with no stipules. The petioles are 2–4 cm long.
The blade is papery, velvety underneath, yellowish or
glaucous and 2.9 cm × 3.1 cm–5.5 cm × 6.0 cm. The apex is
round and the base is ﬂat and the margin is crenate. The
blade has 3 to 5 pairs of secondary nerves and can be seen.
The fruits are glaucous berries, horseshoe-shaped and their
diameter is 6–7 mm. The seeds are spiny with 3 mm × 5 mm
lengthy[5]. In traditional system of medicine various parts of the
plant are used in variety of diseases. In Malaysia, the roots are
traditionally claimed to be effective against diabetes[6]. In
Taiwan, the stems and roots are effectively used to stop
bleeding, inﬂammation, arthritis, sore throat, abdominal pain,
productive cough, colds, headache, abdominal distention,
diaphoretic[7]. In Bangladesh, the plant is also connected for
various ailment and are claimed to be effective for the relief
of fever, loss of movement tongue, muscles pain, joint pain,
muscle disorder, hepatic disorder, diabetes, malaria and
edema[8]. In Indonesia, the plant is used to counteract hair
loss and to resolve swelling of the spleen[3]. The fruits are
claimed for constipation[9]. The leaves and stem of the plant
are used by Vietnam people against snake biting[10]. In China,
the boiling roots of the plant are used for treatment of cough,
laryngitis, pulmonary disease and the leaves are used for
fractures[11]. Despite the traditional uses of the plant, there is
little in vitro investigations have been published. The
alkaloids isolated from plant have been proved a signiﬁcant
effect against chronic diseases like hepatitis B and HIV
virus[11]. Triterpenes isolated from plant have been reported
in vitro anticancer activity[12]. Nowadays in all over the world
people give preference to plant origin drugs as a source for
medication, because of undesirable effects of synthetic drugs,
which are believed to be suitable for chronic treatment.
Traditional plants might provide new compounds, which can
counter the high cost and toxic effects of the current
medicines for many rural populations in developing
countries. As no work has been done on ingestion of
P. glaucus at high doses, the systemic approach in evaluating
their efﬁcacy and safety proﬁle is needed. Therefore, the
present study was aimed to evaluate the safety of P. glaucus
leaves extract with acute and sub-acute toxicity tests in
BALB/c mice.
2. Materials and methods
2.1. Collection and extraction of the plant
The whole plant of P. glaucus was collected in the month of
September 2014 from village Kampung Jeram Kedah, Negeri
Sembilan, Malaysia and authenticated by Ms. Tan Ai Lee at
Forest Research Institute Malaysia, Malaysia where voucher
specimen herbarium with number (SBID: 014/14) was deposited
at the Faculty of Pharmacy. After washing the plant with running
water, the leaves were separated and dried in shade for 20 days
at room temperature. After shade drying, the leaves were grinded
through blender and converted into coarse of powder. The
powder was extracted by continuous hot extraction using the
Soxhlet apparatus at a temperature of 78 C for 48 h using 95%
ethanol. The extract was then concentrated under reduce pres-
sure through rotary evaporator (N-10000, Eyela, Japan). The
extracts were collected and preserved in a desiccator until used
for further studies.2.2. Test animal
Adult healthy BALB/c mice weighting 20–30 g were used
and kept in the animal house of the Department of Pharma-
cology, Lincoln University College, Malaysia. The animals were
kept in plastic cages (34 × 47 × 18 cm3) at animal house, in an
air conditioned environment with ﬁve mice in each cage and
maintained at room temperature of (25 ± 2) C with relative
humidity (60% ± 10%) under 12 h night and light cycle. The
animals used for the experiment were approved by animal ethics
committee of the Lincoln University College, Malaysia.
2.3. Acute toxicity study
The oral acute toxicity study of ethanolic extract of P. glaucus
was evaluated according to Organization for Economic Co-
operation and Development (OECD) guideline 423 on BALB/c
mice (20–30 g)[13], where the limit test dose of 4000 mg/kg was
used. All the animals were kept at overnight fasting before to
every experiment with free excess to water. The animals were
divided into four groups, each comprising 5 animals. The 1st
group served as a negative control, while 2nd, 3rd and 4th was
considered as tested groups received orally P. glaucus
(dissolved in normal saline) extract at dose of 300 mg/kg,
2000 mg/kg and 4000 mg/kg. Before dose administration, the
body weight of each animal was determined and the dose was
calculated according to the body weight. The animals were
observed for any toxic effect for ﬁrst 4 h after the treatment
period. Further animals were investigated for a period of 3 days
for any toxic effect. Behavioral changes and other parameters
such as body weight, urinations, food intake, water intake,
respiration, convulsion, tremor, temperature, constipations,
changes in eye and skin colors, etc.
2.4. Sub-acute toxicity study
The oral sub-acute toxicity study was carried out according to
OECD guideline 407[14]. Adult healthy BALB/c mice (20–30 g)
of each sex were divided into 3 groups of 5 animals each and
were placed under standard conditions. Group I was
considered as control and the other two groups which were
considered as tested groups received the plant extract at a dose
of 600 and 1000 mg/kg body weight respectively for 28
consecutive days[15].2.5. Hematological and biochemical examination
On 29th day, all the animals were sacriﬁced by an anesthesia
(chloroform) after an overnight fasting (8 h). The blood sample
was collected into test tube with and without ethylene diamine
tetra acetic acid as an anticoagulant respectively for biochemical
and hematological parameters. The blood without the ethylene
diamine tetra acetic acid was evaluated for biochemical analysis,
allowed to clot after centrifugation at 2500 r/min for 15 min to
obtain serum and stored at −20 C until assayed for biochemical
estimation. After collecting the blood, all the vital organs such as
liver, kidney, heart, pancreas and small intestine were separated,
weighed each organ on electronic balance and relative organ
body weight of both test treated groups were determined and
compared to control group. The relative organ weight (ROW) of
each organ was calculated as follows[16]:
Table 1
General appearance and behavioral observations of acute toxicity study
for control and treated groups.
Observation Control
group
300
mg/kg
2000
mg/kg
4000
mg/kg
Digestion NO NO NO NO
Body weight Normal Not change Not change Not change
Temperature Normal Normal Normal Normal
Food intake Normal Normal Normal Normal
Urination Normal No effect No effect No effect
Rate of
respiration
Normal No effect No Effect No effect
Change in skin No effect No effect No effect No effect
Drowsiness Not present Not present Present Present
Sedation No effect No effect Observed Observed
Eye color No effect No effect No effect No effect
Diarrhea Not present Not present Not present Not present
General
physique
Normal Normal Lethargy Lethargy
Coma Not present Not present Not present Not present
Death Alive Alive Alive Alive
NO: Not observed.
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2.6. Effect of plant extract on hematological parameters
Red blood cell count, hematocrit, mean cell volume, hemo-
globin, white blood cell count, mean corpuscular hemoglobin,
mean corpuscular hemoglobin concentration, mean corpuscular
volume, monocyte, neutrophil, lymphocyte and platelet count of
the control and plant treated groups were determined and
compared with control group using an automatic haemotology
analyzer (Sysmex K21, Tokyo, Japan).
2.7. Effect of plant extract on serum biochemical
parameters
The biochemical analysis were done on serum after centri-
fugation of collected blood and the following parameters like
aspartate transaminase (AST), alanine transaminase (ALT),
alkaline phosphatase, high density lipoprotein, total bilirubin (T-
BIL), total protein, albumin, urea and creatinine level were
determined for both control and extract treated groups. All an-
alyses were determined on using clinical chemistry analyzer
(Vital Scientiﬁc, Netherlands).
2.8. Statistical analysis
Statistical analysis was performed as mean of
variance ± SEM (n = 5) followed by ANOVA test using Graph
Pad Prism and for multiple comparison test among the groups,
Bonferroni test was performed. A probability level of P < 0.001
was accepted statistically.Table 2
Effect of oral administration of ethanol extract of P. glaucus on average
organ weight (g) of mice.
Organ Average organ weight
Normal 600 mg/kg 1000 mg/kg
Liver 0.872 ± 0.016 0.866 ± 0.016 0.890 ± 0.053
Kidney 0.338 ± 0.011 0.333 ± 0.030 0.355 ± 0.020
Pancreas 0.134 ± 0.011 0.141 ± 0.013 0.129 ± 0.007
Heart 0.161 ± 0.003 0.152 ± 0.010 0.146 ± 0.021
Intestine 0.663 ± 0.019 0.652 ± 0.020 0.662 ± 0.022
Average body
weight on the
sacriﬁce day
25.530 ± 0.140 25.370 ± 0.009 27.500 ± 0.003
Values are expressed as mean ± SEM. P > 0.05 when compared to
control group.
Table 3
Effect of oral administration of ethanol extract of P. glaucus on relative
organs weight (g) of mice.
Organ Relative organs weight
Normal group 600 mg/kg extract 1000 mg/kg extract
Liver 3.410 ± 0.016 3.343 ± 0.016 3.230 ± 0.0533. Results
3.1. Acute toxicity study
The acute toxic effect of ethanolic extract was determined as
per the OECD guideline 423, where the limit test dose of
4000 mg/kg was used. No treatment related toxic symptom or
mortality were observed after oral administration of the tested
plant extract at a dose of 300, 2000 and 4000 mg/kg. The
general behavioral of the extract treated animals and control
group was observed ﬁrst for short period (4 h) followed by long
period (72 h), did not display any drug related changes in
behavior, breathing, skin effects, water consumption, impair-
ment in food intake and temperature. Therefore, the extract
seems to be safe at a dose level of 4000 mg/kg, and the LD50
was considered be >4000 mg/kg. However, there were sign of
sedation, lethargy and drowsiness after the administration of
plant extract at dose of 0.6 g/kg and 1.0 g/kg, compared to
control group. The parameters observed for acute toxicity study
after the administration of the test plant extract compared with
normal group are presented in (Table 1).Kidney 1.320 ± 0.011 1.310 ± 0.030 1.290 ± 0.020
Pancreas 0.524 ± 0.011 0.554 ± 0.013 0.470 ± 0.007
Heart 0.630 ± 0.003 0.599 ± 0.020 0.530 ± 0.021
Intestine 2.590 ± 0.019 2.560 ± 0.020 2.400 ± 0.022
Values are expressed as mean ± SEM. P > 0.05 when compared to
control.3.2. Sub-acute toxicity study
The sub-acute toxic study of the tested plant extract was deter-
mined as per OECD guideline 407. All the tested group animalstreated with plant extract at a dose of 600 and 1000 mg/kg daily
survived throughout the 28 days. No clinical toxicity signs were
observed in the plant treated group compared to the control group.
3.3. Effect of plant extract on relative organ body weight
There was no signiﬁcant difference in average organs and
relative organs weight between control and extract treated group
at a dose of 600 and 1000 mg/kg. The effect plant tested extract
on principal organ weights relative to body weight are shown in
Tables 2 and 3 and Figures 1–3. There were no signiﬁcant
Figure 1. Group-II vital organ of control group.
Figure 2. Group-II treated with 600 mg/kg extract.
Figure 3. Vital organ of Group-III treated with 1000 mg/kg of P. glaucus extract.
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that, the vital organs such as liver, kidney, heart, pancreas and
small intestine were not adversely affected throughout the
treatment by extract. The average and relative organ weight of
tested plant extract and control treated groups shown statistically
non-signiﬁcant differences (P > 0.05).
3.4. Effect of plant extract on hematological parameters
The results of the hematological tests are summarized in
(Table 4 and Figure 1). All the tested hematological parameters
including total blood count, hemoglobin, red blood cell, total
white blood cell, neutrophil, monocyte, lymphocyte, packed cell
volume, and platelet count were within normal limits compared
to control group. No toxicologically signiﬁcant differences
(P > 0.05) between treated animals with the plant extract and
control were found. There were generally no signiﬁcantdifferences noted between control and treated groups for the
hematological parameters measured.
3.5. Effect of plant extract on biochemical parameters
The results of the various biochemical tests on the experi-
mentally treated animals with the plant extract and normal
group are summarized in (Table 5 and Figure 2). Oral
administration of the plant treated extract at a dose of 600 and
1000 mg/kg did not cause signiﬁcant changes in serum
biochemical parameters such as albumin, total protein, glob-
ulin, T-BIL, urea, sodium, creatinine and uric acid levels when
compared to control group. However, SGOT (AST) and SGPT
(ALT) were statistically difference in plant treated group at
dose of 600 and 1000 mg/kg when compared to control group
mice. There was a signiﬁcant increase in (AST) and SGPT
(ALT) level (P < 0.001).
Table 4
Effect of oral P. glaucus extract on hematological parameters.
Parameters Normal group 600 mg/kg extract 1000 mg/kg extract
Total RBC (1012/L) 8.625 ± 0.517 10.170 ± 0.933 9.050 ± 0.710
Hemoglobin (g/L) 11.500 ± 0.610 10.220 ± 1.520 12.270 ± 1.300
PCV (L/L) 41.500 ± 2.020 39.500 ± 2.100 38.460 ± 2.940
MCV (fL) 46.250 ± 1.315 42.250 ± 3.940 49.300 ± 2.500
MCH (pg) 15.000 ± 1.000 14.500 ± 0.645 15.760 ± 0.564
MCHC (g/dL) 33.500 ± 2.900 35.500 ± 0.913 36.000 ± 0.500
Platelet count (109/L) 308.000 ± 33.800 326.500 ± 27.600 292.010 ± 34.600
WBC (109/L) 11.500 ± 1.041 9.000 ± 1.034 10.210 ± 1.470
Neutrophil (%) 26.250 ± 2.680 27.500 ± 1.930 28.000 ± 2.790
Lymphocyte (%) 53.250 ± 5.150 60.250 ± 4.190 58.250 ± 2.600
Monocyte (%) 4.000 ± 1.080 3.500 ± 1.190 2.500 ± 0.645
Values are expressed as mean ± SEM. P > 0.05 when compared to normal control group.
Table 5
Effect of oral P. glaucus extract on biochemical parameters.
Parameters Normal group 600 mg/kg extract 1000 mg/kg extract
Urea (mg/dL) 32.50 ± 3.20 28.70 ± 0.40 27.60 ± 0.10
Creatinine (mg/dL) 1.05 ± 0.15 0.80 ± 0.40 0.80 ± 0.70
Uric acid (mg/dL) 0.51 ± 0.39 0.15 ± 0.05 0.19 ± 0.01
Total cholesterol (mg/dL) 115.90 ± 14.01 107.00 ± 0.50 104.50 ± 17.30
Total protein (g/dL) 6.30 ± 0.90 6.25 ± 0.95 5.85 ± 0.35
Bilirubin (g/dL) 0.35 ± 0.05 0.75 ± 0.25 0.50 ± 0.20
Albumin (g/dL) 2.80 ± 0.30 2.50 ± 0.10 3.50 ± 0.45
Globulin (g/dL) 34.00 ± 3.00 29.00 ± 1.00 29.00 ± 0.05
SGOT (AST) (IU/L) 114.00 ± 25.00 342.50 ± 27.50*** 314.50 ± 16.50***
SGPT (ALT) (IU/L) 36.50 ± 1.50 154.50 ± 42.50*** 165.50 ± 31.00***
Data are expresses as mean ± SEM. ***P < 0.001 when compared to control group.
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According to the World Health Organization, 80% of the
remote area population rely on traditional medicine and the
history of medicinal plants used by human as a medicine is
about 60000 year old[17]. The uses of medicinal plants as a
source of drugs in primary health care have become popular
universally, particularly in developing countries as a safe
because of natural source. The bioactive compound isolated
from herbal plants are believe to be harmless without causing
any side effect on health, and thus is widely used as OTC-
medication[18]. Plant origin drugs are known to play a vital
role in the management various chronic diseases and have
received a great preference by researcher as alternatives
source to allopathic pharmaceutical drugs in recent times[19].
The herbal products today symbolize safety in contrast to the
synthetics that are regarded as unsafe to human and
environment. Malaysia has plenty of medicinal and more
than 1300 medicinal plant species are found in Peninsular
Malaysia alone and the use of medicinal plants as a source
of drugs by Malaysian has always been some thousands of
year ago[20]. However, there is a lack of proven scientiﬁc
studies on the toxicity and adverse effect of these treatments.
Therefore, the present research was aimed to evaluate the
ethanol leaf extract of P. glaucus for acute and sub-acute
toxicity study and to identify the range of dose that could be
used for further studies. The oral acute toxicity study of the
tested plant extract was carried out on BALB/c mice at single
dose of 300, 2000 and 4000 mg/kg body weight and was
continuously monitored for ﬁrst 4 h, followed for a period of72 h for any toxic effect after the treatment period. No major
changes in behavior and mortality were observed in all groups.
However, sedation, lethargy and drowsiness were conﬁrmed in
2000 and 4000 mg/kg body weight in treated group. The
extract seems to be safe at a dose level of 4000 mg/kg, and the
LD50 is considered be >4000 mg/kg. Any pharmaceutical drug
or compound with the oral LD50 higher than 1000 mg/kg could
be considered safe and low toxic[21]. This suggests that the
ethanolic extract of P. glaucus is practically non-toxic in sin-
gle dose of level 4000 mg/kg body weight. However in case of
multiple dose uses in the treatment of the chronic disorder like
cancer, diabetes or hyperlipidemia, whether it will be safe and
have no effect on relative organ weight, hematological and
biochemical parameters that can be conﬁrmed from its sub-
acute toxicity study. A sub-acute toxicity study was therefore
carried out with doses of 0.6 and 1 g/kg of extract as per OECD
guideline[22]. Decreases or increases in the body weights are
associated with toxic effects of chemicals and drugs.
However, scientiﬁc evidence conﬁrmed that increases or
decreases in the body weights are accompanied with
accumulation of fats and physiological adaptation responses
to the plant extracts rather than to the toxic effects of
chemicals or drugs that lead to decrease appetite and, hence,
lower caloric intake by the animal[23]. The relative weight of
the vital organs like liver, kidney, heart, pancreas and small
intestine were found normal indicating no toxic effect in both
control and treated group and was statistically non-signiﬁcant
differences (P > 0.05). The absence of any signiﬁcant differ-
ences in the liver, kidney, heart and small intestine weight
provides support for the safety of P. glaucus. After 28 days of
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ters showed no signiﬁcance P > 0.05 when compared to con-
trol group. The bone marrow is responsible for the production
of the blood cell and some phytochemicals isolated from plant
have affect red blood cell levels[24]. Hence, the tested plant
extract may not have harmful effects on bone marrow
function and justify the fact that at all doses of P. glaucus
does not induce anemia, making it safe. Similarly, estimation
of serum biochemical parameters in treated animals showed
non-signiﬁcance (P > 0.05) compared to control group.
However, the transaminases enzyme SGOT (AST) and SGPT
(ALT) were observed positive and showed a remarkable sig-
niﬁcant elevation (P < 0.001) in plant treated animal for 600
and 1000 mg/kg extract as compared to respective control
group. Many studies have conﬁrmed that elevated serum levels
of hepatic enzymes, transaminases (SGPT and SGOT) are not a
directly linked for liver injury but increase levels are respon-
sible to cause inﬂammation, cellular leakage and damage of
cell membrane to cells in the liver[25]. The main target organ for
drug or bioactive active compound is liver where exposed to
the foreign substances being absorbed in intestines and
metabolized to other compounds which may or may not be
hepatotoxic to the mice[26]. Therefore, the increase in liver
hepatic enzyme (SGPT and SGOT) after administration of
the ethanolic plant extract might be because of certain
phytochemical compound that might have toxic potential on
liver with increasing dose and result liver injury. However,
these changes may not be toxicologically signiﬁcant, as they
were not corroborated by the biochemical ﬁndings (ALT,
AST). Further speciﬁc assays of toxicity and more
histological study could provide more information regarding
to the toxic effect of the extract on liver.
This study provides very important data on the acute and sub-
acute toxicity proﬁle of the ethanolic extract of P. glaucus that
should be very useful for any future in vivo and clinical study of
this plant medicine. P. glaucus extract was found to be less toxic
when oral sub-acute toxicities in mice were performed. These
results showed that the use of extract of P. glaucus is safe and
explained the extensive use of the plant as a traditional medicine
in Malaysia.
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